Article Versions Notes

Issa II, Due H, Brøndum RF, Veeravakaran V, Haraldsdóttir H, Sylvester C, Brogaard A, Dhanjal S, Schmierer B, Dybkær K. CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers. 2024; 16(13):2437. https://doi.org/10.3390/cancers16132437

Issa, Issa Ismail, Hanne Due, Rasmus Froberg Brøndum, Vidthdyan Veeravakaran, Hulda Haraldsdóttir, Cathrine Sylvester, Asta Brogaard, Soniya Dhanjal, Bernhard Schmierer, and Karen Dybkær. 2024. "CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma" Cancers 16, no. 13: 2437. https://doi.org/10.3390/cancers16132437

Issa, I. I., Due, H., Brøndum, R. F., Veeravakaran, V., Haraldsdóttir, H., Sylvester, C., Brogaard, A., Dhanjal, S., Schmierer, B., & Dybkær, K. (2024). CRISPR-Cas9 Knockout Screens Identify DNA Damage Response Pathways and BTK as Essential for Cisplatin Response in Diffuse Large B-Cell Lymphoma. Cancers, 16(13), 2437. https://doi.org/10.3390/cancers16132437